Professor Alastair Noyce, BMedSci, MB BS, MSc, MRCP, PhD, FHEAProfessor in Neurology and Neuroepidemiology and Consultant NeurologistEmail: a.noyce@qmul.ac.ukProfileResearchPublicationsSupervisionProfileI am a Professor in Neurology and Neuroepidemiology in the Centre for Preventive Neurology (CPN), in the Wolfson Institute of Population Health, Queen Mary University of London (QMUL). I am the deputy lead for the CPN and a Consultant Neurologist at Barts Health NHS Trust. I graduated from Barts and the London (QMUL) in 2007 and I pursued integrated training via the Foundation Academic Programme and an NIHR Academic Clinical Fellowship at UCL. Between 2012-2016 I undertook a PhD in Neuroscience at UCL and between 2014-2016 I undertook an MSc in Epidemiology at London School of Hygiene and Tropical Medicine. I re-joined QMUL and the PNU in 2017 to lead the Parkinson’s programme of work. My research interests are Parkinson’s disease and other neurodegenerative disorders, particularly early identification and epidemiological aspects, including environmental, clinical and genetic determinants. I am the co-principal investigator of the PREDICT-PD study, principal investigator for the East London Parkinson’s Disease project and chief investigator for the Access-PD study. I am a member of the International Parkinson and Movement Disorder Society (MDS). I graduated from the MDS LEAP leadership programme in 2020, and then became a member of the faculty for the LEAP, teaching leadership skills to early career movement disorders specialists around the world. I am the Chair of the MDS Epidemiology Study Group, a member of the MDS Early Onset PD Study Group and the Equality of Access to Care Committee. I on the Global Parkinson’s Genetics Program (GP2) and lead two of its working groups, focusing on Training and Networking and Prodromal PD. I am Associate Editor for the Journal of Parkinson’s Disease. Away from neurodegenerative disease, I am interested in the emerging link between recreational use of nitrous oxide (laughing gas) and neurological harm. I have led the drafting of national guidance for managing the range of neurological conditions associated with nitrous oxide, as well as describing the clinical manifestations in patients in order to raise awareness amongst healthcare workers. ResearchResearch Interests:Neurology Epidemiology Genetics Predictive models Clinical researchPublications Sanyaolu AO, Mohamed W, Makarious MB et al. (2025). Chapter 4 Mendelian randomization and Parkinson’s disease. nameOfConference DOI: 10.1016/b978-0-443-13550-7.00006-9 QMRO: qmroHref Kim JJ, Bandres-Ciga S, Heilbron K et al. (publicationYear). Bidirectional relationship between olfaction and Parkinson’s disease. nameOfConference DOI: 10.1038/s41531-024-00838-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103252 Tan AH, Saffie-Awad P, Schuh AFS et al. (2024). Global Perspectives on Returning Genetic Research Results in Parkinson Disease. nameOfConference DOI: 10.1212/nxg.0000000000200213 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103254 Brolin KA, Schaeffer E, Kuri A et al. (2024). Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications. nameOfConference DOI: 10.1002/mds.30067 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103253 Bramich S, Noyce A, Pérez-Carbonell L et al. (2024). P027 Dream characteristics are sex-specific in REM Sleep Behaviour Disorder and healthy older adults. nameOfConference DOI: 10.1093/sleepadvances/zpae070.109 QMRO: qmroHref Mahlknecht P, Leiter S, Horlings C et al. (2024). Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study. nameOfConference DOI: 10.1002/mdc3.14264 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103255 Azoidou V, Noyce AJ, Simonet C (2024). The effect of tactile cueing on dual task performance in Parkinson’s disease. A systematic review and meta-analysis. nameOfConference DOI: 10.1016/j.prdoa.2024.100284 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103256 Step K, Eltaraifee E, Elsayed I et al. (2024). Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program. nameOfConference DOI: 10.1002/mds.30051 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103257 Lim S-Y, Tan AH, Ahmad-Annuar A et al. (2024). Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic. nameOfConference DOI: 10.1016/s1474-4422(24)00378-8 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99549 Pereira GM, Teixeira-dos-Santos D, Soares NM et al. (publicationYear). A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries. nameOfConference DOI: 10.1038/s41531-024-00779-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103259 View Profile Publication Page SupervisionJonggeol Kim, Global Parkinson's Genetics Programme, Genetic Determinants of Parkinson's Disease Benjamin Jacobs (subsidiary supervisor), MRC, Genetic Association study in individuals of Diverse Ancestral backgrounds with Multiple Sclerosis (ADAMS) Alex Zirra, The Medical College of St Bartholomew’s Hospital Trust, Cognitive features of Parkinson’s disease in a diverse population Ellen Camboe, Barts Charity, Parkinson’s Disease Psychosis in a Diverse Population Harneek Chohan, Early clinical and biological markers in Parkinson's Disease